R

Retina Consultants of Charleston | Retina Research of Beaufort

Research site
(Unclaimed)
Location
1181 Ribaut Road, Suite 200, Beaufort, South Carolina, United States of America
Site insights

Top conditions

Macular Degeneration (4 trials)

Edema (2 trials)

Macular Edema (2 trials)

Geographic Atrophy (2 trials)

Atrophy (2 trials)

Top treatments

KSI-301
Aflibercept
Avacincaptad pegol
Zimura

Parent organization

This site is a part of Retina Consultants of Charleston

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

2 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Patients who completed Study ISEE2008 (GATHER2) and consent to participate will be administered monthly avacincaptad pegol 2 mg.

Active, not recruiting
Macular Degeneration
Geographic Atrophy
Drug: Avacincaptad pegol 2 mg intravitreal injection

RGX-314 is being developed as a novel one-time gene therapy for the treatment of neovascular (wet) age-related macular degeneration (wet AMD). Wet AM...

Enrolling
Wet Age-related Macular Degeneration
WetAMD
Genetic: RGX-314 Dose 2
Biological: Aflibercept (EYLEA®)

Trial sponsors

Kodiak Sciences logo

Kodiak Sciences (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems